Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Pegylated interferon-α (PEG-IFN-α) forms an integral part of the current treatment for hepatitis C virus (HCV) infection. PEG-IFN-α suppresses HCV production by augmenting the innate antiviral immune response. Recent studies have reported the induction of hepcidin, the iron regulatory hormone, by IFN-α in vitro . As hepcidin plays an important role in innate immunity, we hypothesized that this finding may be of clinical relevance to HCV and investigated the changes in iron homeostasis during the first 24 hours of treatment. Blood samples were obtained from HCV patients immediately prior to and 6, 12, and 24 hours following the first dose of PEG-IFN-α/ribavirin (RBV). Samples were analyzed for hepcidin, cytokine, iron levels, and HCV viral load, and hepcidin messenger RNA (mRNA) expression was quantified in peripheral blood mononuclear cells. Hepcidin induction by IFN-α was further analyzed in cell culture. In HCV patients a single dose of PEG-IFN-α/RBV resulted in a significant increase in serum hepcidin, peaking at 12 hours, coinciding with a 50% reduction in serum iron and transferrin saturation over the 24-hour period. Patients with a ≥2 log decline in HCV viral load over the first 24 hours had significantly lower SI and TS levels at 12 and 24 hours. Moreover, 24-hour SI levels were an independent predictor of the immediate HCV viral decline, an indicator of ultimate treatment outcome. In cell culture, a direct induction of hepcidin by IFN-α was seen, controlled by the STAT3 transcription factor. Conclusion : Hepcidin induction occurs following the initiation of PEG-IFN-α treatment for HCV, and is mediated by way of STAT3 signaling. The subsequent hypoferremia was greatest in those with the most significant decline in viral load, identifying systemic iron withdrawal as a marker of immediate interferon-α efficacy in HCV patients. (HEPATOLOGY 2012)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“The inflammatory induction of hepcidin is chiefly mediated by interleukin 6 (IL-6), whereas other cytokines have also been implicated.(22,23) To investigate the stimulus for hepcidin production following PEG-IFN-a/RBV, serum levels of a panel of cytokines were measured in a subgroup of 22 patients at time 0, 12, and 2…”
BackgroundResultHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Through its inhibitory interaction with the iron exporter ferroportin, hepcidin functions to limit iron release from macrophages and duodenal enterocytes, thereby lowering plasma iron levels.(14,15) In this setting, systemic iron withdrawal is thought to represent an important innate immune response mechanism.”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567 · cited 1×
“Inflammation increases hepcidin expression by way of the Janus kinase (Jak)/STAT signaling pathway, with the STAT3 transcription factor essential to this process.(23,26) Therefore, the possible role of STAT3 in the induction of hepcidin by IFN-a was investigated next.”
BackgroundSelf-citationTime-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
STAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., Corradini, E., Ernst, M., Klein, C., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.018 · Cited by 315 · cited 3×
“(SOCS3) has been reported in nonresponders to treatment in HCV, whereas this molecule also inhibits the induction of hepcidin by inflammation, and potentially its downstream effects on iron regulation.(23,51) This interference may be reflected in the differences in the ability of hepcidin to regulate iron levels betwe…”
BackgroundSTAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6
Zhang, D., Sun, M., Samols, D., & Kushner, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9503 · Cited by 309
Iron in innate immunity: starve the invaders
Ganz, T. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.011 · Cited by 284 · cited 3×
“In this setting, systemic iron withdrawal is thought to represent an important innate immune response mechanism.(12) Here we hypothesized that the direct stimulation of hepcidin by IFN-a and the subsequent responses could be of clinical relevance.”
BackgroundInfluentialLee, P., Peng, H., Gelbart, T., & Beutler, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403108101 · Cited by 221
Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C
Fujita, N., Sugimoto, R., Takeo, M., Urawa, N., Mifuji, R., Tanaka, H., Kobayashi, Y., Iwasa, M., Watanabe, S., Adachi, Y., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00057.fujita · Cited by 211
De Domenico, I., Zhang, T. Y., Koening, C. L., Branch, R. W., London, N., Lo, E., Daynes, R. A., Kushner, J. P., Li, D., Ward, D. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42011 · Cited by 197 · cited 1×
“(SOCS3) has been reported in nonresponders to treatment in HCV, whereas this molecule also inhibits the induction of hepcidin by inflammation, and potentially its downstream effects on iron regulation.(23,51) This interference may be reflected in the differences in the ability of hepcidin to regulate iron levels betwe…”
BackgroundKato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2095-z · Cited by 172
Casanovas, G., Mleczko-Sanecka, K., Altamura, S., Hentze, M. W., & Muckenthaler, M. U. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0447-2 · Cited by 161
Self-citationVerga Falzacappa, M. V., Casanovas, G., Hentze, M. W., & Muckenthaler, M. U. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0313-7 · Cited by 146
Self-citationFine tuning of hepcidin expression by positive and negative regulators
Muckenthaler, M. U. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.009 · Cited by 83
Self-citation
Research works printed but not linked: 31
- Ghany, 2009, Diagnosis, management, and treatment of hepatitis C: an update., HEPATOLOGY, 49, 13351374, 10.1002/hep.22759 · DOI · Paper page
- Feld, 2005, Mechanism of action of interferon and ribavirin in treatment of hepatitis C., Nature, 436, 967972, 10.1038/nature04082 · DOI · Paper page
- Huang, 2007, Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C., Gastroenterology, 132, 733744, 10.1053/j.gastro.2006.11.045 · DOI
- Neumann, 1998, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferonalpha therapy., Science, 282, 103107, 10.1126/science.282.5386.103 · DOI · Paper page
- Devitt, 2010, Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h., Eur J Gastroenterol Hepatol, 22, 12111220, 10.1097/MEG.0b013e32833caf7b · doi:10.1097/meg.0b013e32833caf7b
- DuranteMangoni, 2009, Correlates and prognostic value of the firstphase hepatitis C virus RNA kinetics during treatment., Clin Infect Dis, 49, 498506
- Zhang, 2010, Hepcidin expression by human monocytes in response to adhesion and proinflammatory cytokines., Biochim Biophys Acta, 1800, 12621267
- Bartolomei, 2011, Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes., J Gen Virol, 92, 20722081, 10.1099/vir.0.032706-0 · DOI
- Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization., Science, 306, 20902093, 10.1126/science.1104742 · DOI · Paper page
- Swinkels, 2008, Advances in quantitative hepcidin measurements by timeofflight mass spectrometry., PLoS ONE, 3, e2706, 10.1371/journal.pone.0002706 · DOI · Paper page
- van Dijk, 2008, Serum hepcidin levels are innately low in HFErelated haemochromatosis but differ between C282Yhomozygotes with elevated and normal ferritin levels., Br J Haematol, 142, 979985, 10.1111/j.1365-2141.2008.07273.x · DOI · Paper page
- Pinto, 2010, Hepcidin messenger RNA expression in human lymphocytes., Immunology, 130, 217230, 10.1111/j.1365-2567.2009.03226.x · DOI · Paper page
- Lanford, 2006, Genomic response to interferonalpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics., HEPATOLOGY, 43, 961972, 10.1002/hep.21167 · DOI · Paper page
- Ferrara, 2009, Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C., Am J Gastroenterol, 104, 605616
- Bonkovsky, 2006, Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C., Gastroenterology, 131, 14401451, 10.1053/j.gastro.2006.08.036 · DOI
- Desai, 2008, Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a metaanalysis of six prospective randomized controlled trials., Dig Dis Sci, 53, 815822, 10.1007/s10620-007-9945-7 · DOI
- Di Bisceglie, 1992, Measurement of iron status in patients with chronic hepatitis., Gastroenterology, 102, 21082213, 10.1016/0016-5085(92)90339-Z · DOI · Paper page
- Bonkovsky, 1997, Iron and chronic viral hepatitis., HEPATOLOGY, 25, 759768, 10.1002/hep.510250345 · DOI · Paper page
- Piperno, 1998, Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations., HEPATOLOGY, 28, 11051109, 10.1002/hep.510280427 · DOI · Paper page
- Fujita, 2007, Hepatic iron accumulation is associated with disease progression and resistance to interferonribavirin combination therapy in chronic hepatitis C., J Gastroenterol Hepatol, 22, 18861893, 10.1111/j.1440-1746.2006.04759.x · DOI · Paper page
- Girelli, 2009, Reduced serum hepcidin levels in patients with chronic hepatitis C., J Hepatol, 51, 845852, 10.1016/j.jhep.2009.06.027 · DOI · Paper page
- Kakizaki, 2000, Iron enhances hepatitis C virus replication in cultured human hepatocytes., Liver, 20, 125128, 10.1034/j.1600-0676.2000.020002125.x · DOI · Paper page
- Theurl, 2004, Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3., J Infect Dis, 190, 819825, 10.1086/422261 · DOI · Paper page
- Fillebeen, 2010, Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells., J Hepatol, 53, 995999, 10.1016/j.jhep.2010.04.044 · DOI
- Bonkovsky, 1996, Iron in liver diseases other than hemochromatosis., Semin Liver Dis, 16, 6582, 10.1055/s-2007-1007220 · DOI · Paper page
- Kageyama, 2000, Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C., Am J Gastroenterol, 95, 10411050, 10.1111/j.1572-0241.2000.01979.x · DOI · Paper page
- Fujita, 2008, Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion., J Hepatol, 49, 702710, 10.1016/j.jhep.2008.05.014 · DOI
- Viatte, 2006, Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice., Blood, 107, 29522958, 10.1182/blood-2005-10-4071 · DOI · Paper page
- Yang, 1998, STAT3 complements defects in an interferonresistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities., Proc Natl Acad Sci U S A, 95, 55685572, 10.1073/pnas.95.10.5568 · DOI · Paper page
- Larrea, 2006, Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies., Gut, 55, 11881196
- Zhang, 1996, STAT3 participates in transcriptional activation of the Creactive protein gene by interleukin6., J Biol Chem, 271, 95039509
Cited by
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Hepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686
Rodriguez, R., Jung, C.-L., Gabayan, V., Deng, J. C., Ganz, T., Nemeth, E., & Bulut, Y. (2014) · Infection and Immunity · doi:10.1128/iai.00983-13 · Cited by 127
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections
Armitage, A. E., Stacey, A. R., Giannoulatou, E., Marshall, E., Sturges, P., Chatha, K., Smith, N. M. G., Huang, X., Xu, X., Pasricha, S.-R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402351111 · Cited by 101
Riedelberger, M., Penninger, P., Tscherner, M., Seifert, M., Jenull, S., Brunnhofer, C., Scheidl, B., Tsymala, I., Bourgeois, C., Petryshyn, A., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.023 · Cited by 64
Metadata
- Authors
- Ryan, J. D., Altamura, S., Devitt, E., Mullins, S., Lawless, M. W., Muckenthaler, M. U., & Crowe, J.
- Venue
- Hepatology
- Published
- 2012-08
- Volume
- 56
- Issue
- 2
- Pages
- 492-500
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2025954883
- Cited by
- 49
- References
- 18
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1126 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.